Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lirilumab

Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN) .

Product Specifications

CAS Number

1000676-41-4

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Virus Protease

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

KCNG2 Polyclonal Antibody
MBS2525166-01 0.02 mL

KCNG2 Polyclonal Antibody

Sign In for Pricing
View Details
KCNG2 Polyclonal Antibody
MBS2525166-02 0.06 mL

KCNG2 Polyclonal Antibody

Sign In for Pricing
View Details
KCNG2 Polyclonal Antibody
MBS2525166-03 0.12 mL

KCNG2 Polyclonal Antibody

Sign In for Pricing
View Details
KCNG2 Polyclonal Antibody
MBS2525166-04 0.2 mL

KCNG2 Polyclonal Antibody

Sign In for Pricing
View Details
KCNG2 Polyclonal Antibody
MBS2525166-05 5x 0.2 mL

KCNG2 Polyclonal Antibody

Sign In for Pricing
View Details
Recombinant DARPP-32 Monoclonal Antibody
AN300621L-01 50 µL

Recombinant DARPP-32 Monoclonal Antibody

Sign In for Pricing
View Details